Sea Snake Envenomation Medication

  • Author: Dimitrios Papanagnou, MD, MPH; Chief Editor: Rick Kulkarni, MD   more...
 
Updated: Feb 8, 2011
 

Medication Summary

The mainstay of medical therapy for sea snake venom poisoning is antivenom. If time permits, a skin test for sensitivity to horse serum may be performed before antivenom administration. The purpose of skin testing is to try to predict possible anaphylaxis, rather than determine whether antivenom should be used. Omit skin testing if the patient clearly needs antivenom because skin testing reliability is low. Closely monitor the patient during antivenom administration and begin aggressive treatment if any evidence of allergic reaction is observed.

Next

Antivenom

Class Summary

Antivenom conveys passive immunity to patients with sea snake bite.

Antivenin polyvalent sea snake

 

Can be obtained from Commonwealth Serum Laboratories, Melbourne, Australia. DOC for treatment of symptomatic sea snake envenomation. Is a hyperimmune horse globulin prepared against the venoms of Enhydrina schistosa and N scutatus and is efficacious in the treatment of all sea snake envenomations.

An alternative to polyvalent sea snake antivenom is monovalent sea snake antivenom (Haffkine Institute, Bombay, India), prepared against the venom of E schistosa, which is effective against most sea snake venoms. Finally, tiger snake (N scutatus) antivenom (Commonwealth Serum Laboratories, Melbourne, Australia) displays substantial activity against sea snake venoms because of a close relationship between tiger snake and sea snake venoms.

Early or mild envenomation can be treated with 1 ampule, while late and/or severe envenomations should be treated with 3-10 ampules. Snake antivenom only is administered IV.

IV infusion should be started at a slow rate, which may be increased if no evidence of significant allergic reaction exists. Most authorities recommend premedication with diphenhydramine.

Previous
Next

Antihistamines

Class Summary

These agents are used to treat minor allergic reactions and anaphylaxis.

Diphenhydramine (Benadryl)

 

May be used to pretreat patients with prior documentation of minor allergic reactions. Used as a prophylactic treatment and for treatment of allergic reactions to antivenom.

Previous
Next

Immunizations

Class Summary

Active immunity can prevent hypersensitivity reactions and neutralize toxoids.

Diphtheria & tetanus toxoids

 

Used to induce active immunity against tetanus in selected patients. The immunizing agents of choice for most adults and children >7 y are tetanus and diphtheria toxoids. Necessary to administer booster doses to maintain tetanus immunity throughout life.

Pregnant patients should receive only tetanus toxoid, not a diphtheria antigen–containing product.

In children and adults, may administer into the deltoid or midlateral thigh muscles. In infants, the preferred site of administration is the mid thigh laterally.

The tetanus immunization status should be updated for any patient bitten by a sea snake. The precise formulation used is dependent on the patient's age and prior immunization status.

Previous
Next

Cardiovascular agents

Class Summary

These agents are useful for treatment or prophylaxis of acute allergic reactions and for support of blood pressure in patients with shock.

Epinephrine (Epi-Pen, Adrenaline)

 

DOC for the treatment of anaphylactoid reactions and should be considered as pretreatment before giving antivenom. Has alpha-agonist effects that include increased peripheral vascular resistance, reversed peripheral vasodilatation, systemic hypotension, and vascular permeability. Beta-agonist effects include bronchodilatation, chronotropic cardiac activity, and positive inotropic effects.

Previous
Next

Corticosteroids

Class Summary

Anti-inflammatory agents are useful in the management of acute and delayed allergic reactions to sea snake envenomation or antivenom administration.

Methylprednisolone (Solu-Medrol, Depo-Medrol)

 

Steroids ameliorate delayed effects of anaphylactoid reactions and may limit biphasic anaphylaxis. In severe cases of serum sickness, parenteral steroids may be beneficial to reduce inflammatory effects of this immune-complex mediated disease.

Prednisone (Deltasone, Orasone, Meticorten)

 

Decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing increased capillary permeability.

Previous
Proceed to Follow-up
 
 
Contributor Information and Disclosures
Author

Dimitrios Papanagnou, MD, MPH  Staff Physician, Department of Emergency Medicine, Bellevue Hospital Center

Dimitrios Papanagnou, MD, MPH is a member of the following medical societies: American College of Emergency Physicians, American College of Physicians-American Society of Internal Medicine, American Medical Student Association/Foundation, and Emergency Medicine Residents Association

Disclosure: Nothing to disclose.

Coauthor(s)

Susi U Vassallo, MD, FACEP, FACMT  Assistant Professor of Emergency Medicine, New York University School of Medicine/Bellevue Hospital Center

Susi U Vassallo, MD, FACEP, FACMT is a member of the following medical societies: American Academy of Clinical Toxicology, American College of Emergency Physicians, American College of Medical Toxicology, New York Academy of Medicine, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Robert L Norris, MD  Professor, Department of Surgery, Chief, Division of Emergency Medicine, Stanford University Medical Center

Robert L Norris, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, California Medical Association, International Society of Toxinology, Society for Academic Emergency Medicine, and Wilderness Medical Society

Disclosure: Nothing to disclose.

John T VanDeVoort, PharmD  Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists

Disclosure: Nothing to disclose.

James Steven Walker, DO, MS  Clinical Professor of Surgery, Department of Surgery, University of Oklahoma College of Medicine

James Steven Walker, DO, MS is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Osteopathic Emergency Physicians, and American Osteopathic Association

Disclosure: Nothing to disclose.

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, James Foster, MD, to the development and writing of this article.

References
  1. Food and Agriculture Organization. Sea Snakes. United Nations; August 2007. [Full Text].

  2. Ditmars RL. The MacMillan Company. Reptiles of the World, Revised Edition. 1933:329, pp 89.

  3. Auerbach PS. Marine envenomations. N Engl J Med. Aug 15 1991;325(7):486-93. [Medline].

  4. Auerbach PS. Marine envenomations. In: Auerbach PS, ed. Wilderness Medicine: Management of Wilderness and Environmental Emergencies. 3rd ed. Mosby-Year Book; 1995:1327-74.

  5. Baxter EH, Gallichio HA. Cross-neutralization by tiger snake (Notechis scutatus) antivenene and sea snake (Enhydrina schistosa) antivenene against several sea snake venoms. Toxicon. May 1974;12(3):273-8. [Medline].

  6. Chetty N, Du A, Hodgson WC, et al. The in vitro neuromuscular activity of Indo-Pacific sea-snake venoms: efficacy of two commercially available antivenoms. Toxicon. Aug 2004;44(2):193-200. [Medline].

  7. Dunson WA. The Biology of Sea Snakes. Baltimore, Md: University Park Press; 1975.

  8. Guenin DG, Auerbach PS. Trauma and envenomations from marine fauna. In: Tintinalli, et al, eds. Emergency Medicine: A Comprehensive Study Guide. 4th ed. McGraw-Hill; 1996:868-73.

  9. Heatwole H. Sea Snakes. Krieger Publishing Company; 1999.

  10. Minton SA Jr. Paraspecific protection by elapid and sea snake antivenins. Toxicon. Jul 1967;5(1):47-55. [Medline].

  11. Pinney R. Sea snakes. Reptile & Amphibian. 1994;26:22-34.

  12. Reid HA. Antivenom in sea-snake bit poisoning. Lancet. Mar 15 1975;1(7907):622-3. [Medline].

  13. Reid HA. Epidemiology of sea-snake bites. J Trop Med Hyg. May 1975;78(5):106-13. [Medline].

  14. Reid HA, Chan KE. The paradox in therapeutic defibrination. Lancet. Mar 9 1968;1(7541):485-6. [Medline].

  15. Senanayake MP, Ariaratnam CA, Abeywickrema S. Two Sri Lankan cases of identified sea snake bites, without envenoming. Toxicon. Jun 1 2005;45(7):861-3. [Medline].

  16. Tu AT. Biotoxicology of sea snake venoms. Ann Emerg Med. Sep 1987;16(9):1023-8. [Medline].

  17. Tu AT, Fulde G. Sea snake bites. Clin Dermatol. Jul-Sep 1987;5(3):118-26. [Medline].

  18. Vick JA. Medical studies of poisonous land and sea snakes. J Clin Pharmacol. Jun 1994;34(6):709-12. [Medline].

Previous
Next
 
Technique for application of pressure immobilization in field management of sea snake bites. Figure 1, Apply a broad-pressure bandage over the bite site as soon as possible. Do not take off jeans because the movement of doing so assists venom to enter the bloodstream. Keep the bitten leg still. Figure 2, The bandage should be as tight as would be applied to a sprained ankle. Figure 3, Extend the bandage as high as possible.
Technique for application of pressure immobilization in field management of sea snake bites. Figure 4, Apply a splint to the leg. Figure 5, Bind the splint firmly to as much of the leg as possible. If the bandages and splint are applied correctly, they will be comfortable and may be left on for several hours. They should not be taken off until the patient has reached medical care. The doctor will decide when to remove the bandages. If venom has been injected, it will move into the bloodstream quickly once the bandages are removed. The doctor should leave the bandages and splint in position until he or she has assembled appropriate antivenom and drugs that may need to be used when the dressings and splint are removed. Figure 6, For bites on a hand or forearm, bind to the elbow with bandages, use a splint to the elbow, and use a sling.
Yellow-belly pelagic sea snake.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.